Drug pricing

News

PhRMA sues Trump administration over GLOBE rebate scheme

PhRMA is challenging the Trump administration's GLOBE model for Most-Favoured Nation pricing in Medicare Part B in a US district court.

News

GLOBE model finalised, with narrowed scope and fewer savings

CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.

News

PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.

News

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."

News

Advocacy group pokes holes in Trump's MFN pricing claims

Public Citizen says claims for the drug price savings that are being delivered by Trump's Most-Favoured Nation deals with pharma are "a mirage."

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

PhRMA sues Trump administration over GLOBE rebate scheme

GLOBE model finalised, with narrowed scope and fewer savings

PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

Pharma leaders urge Europe to halt 'slow agony' of decline

Advocacy group pokes holes in Trump's MFN pricing claims

How new PBM transparency rules will alter drug pricing

argenx's Forte acquisition delivers coeliac trial win

Discover a new era of healthcare panel engagement: Grounded ...

Drug pricing

Editor's Picks